Drug Topics

DECEMBER 15, 2023

Immunizations against influenza, COVID-19, and RSV are lower than they were this time last year, and hospitalizations have increased across all age groups.

Vaccines 194

Vaccines Immunization Hospitals 194

Pharmacy Times

DECEMBER 15, 2023

Investigators also found that the results demonstrated lower death and hospitalization rates for those with advanced heart failure treated with cell therapy.

Hospitals 160

Hospitals 160

STAT

DECEMBER 15, 2023

A Texas woman’s unsuccessful legal fight for an abortion on medical emergency grounds drew nationwide headlines in recent days, but her plight is hardly a rare occurrence amid vague and highly restrictive state laws in the post-Roe era. Kate Cox is likely one of hundreds, if not thousands, of Texans who’ve faced a similar struggle this year to get an abortion for medical reasons, according to a STAT review of studies and abortion data from other states.

145

145

Drug Topics

DECEMBER 15, 2023

Lupin gained FDA approval for varenicline tablets (0.5 mg and 1 mg) and launched its already-approved Turqoz (norgestrel and ethinyl estradiol) tablets USP, 0.3 mg/0.03 mg earlier this month.

FDA 112

FDA 112

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

DECEMBER 15, 2023

A National Institutes of Health working group on Friday recommended a sizable increase in salaries of postdoctoral researchers and a cap on the length of the position in an effort to secure the future of academia’s research workforce amid an unprecedented exodus of young life scientists to industry. The group called for raising minimum postdoc salaries to $70,000 beginning next year — an increase of more than 20% — and adjusting wages for annual inflation, as well as limitin

145

145

Pharmacy Times

DECEMBER 15, 2023

The researchers emphasized that individuals must advocate for new policies that could aid regulation of harmful information being shared through social media platforms.

132

132

Pharmacy Times

DECEMBER 15, 2023

Stress usually occurs as a byproduct of workplace powerlessness because feelings of powerlessness at work prevent us from being the kind of human beings we need to be.

132

132

Fierce Healthcare

DECEMBER 15, 2023

Google continues to advance its generative AI models designed specifically for healthcare use cases. | Google this week unveiled MedLM, a family of foundation models designed for healthcare industry use cases and available through Google Cloud.

132

132

Fierce Pharma

DECEMBER 15, 2023

About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at the European Academy of Dermatology and Venereology congress 2022, the company has clinched a second FDA OK. | About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at the European Academy of Dermatology and Venereology congress 2022, the company has clinched a second FDA OK.

FDA 129

FDA 129

Fierce Healthcare

DECEMBER 15, 2023

The danger of cybercrime and security breaches looms over the healthcare industry like a slow-moving storm. | Shifting targets, indirect angles of attack and increasing regulatory expectations await hospitals and health systems in the coming year, cybersecurity experts say.

Hospitals 132

Hospitals 132

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

DECEMBER 15, 2023

The proposed Vaccine Injury Compensation Modernization Act is intended to bring valuable updates to the 36-year-old legislation.

Vaccines 139

Vaccines 139

Fierce Healthcare

DECEMBER 15, 2023

More than two dozen healthcare payers and providers, including CVS, Premera Blue Cross and Mass General Brigham, are making voluntary safety, security and transparency commitments to the White Hous | More than two dozen healthcare payers and providers are making voluntary safety, security and transparency commitments to the White House regarding the use of artificial intelligence.

129

129

Fierce Pharma

DECEMBER 15, 2023

Since Merck secured approval for kidney cancer pill and blockbuster hopeful Welireg (belzutifan) in August of 2021, sales have grown slowly but surely. | Since Merck secured approval for kidney cancer pill and blockbuster hopeful Welireg (belzutifan) in August of 2021, sales have grown slowly but surely. With a second FDA nod for a much larger patient population, the company can anticipate a more pronounced upswing in revenue from the hypoxia-inducible factor-2 alpha (HIF-2a) inhibitor.

FDA 121

FDA 121

Fierce Healthcare

DECEMBER 15, 2023

While its merger with Humana may have fallen through for now, Cigna is attracting plenty of interest for the rumored sale of its Medicare Advantage business, Bloomberg reported. | While its merger with Humana may have fallen through for now, Cigna is attracting plenty of interest for the rumored sale of its Medicare Advantage business, Bloomberg reported.

121

121

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

DECEMBER 15, 2023

MSD and Moderna’s individualised cancer vaccine mRNA-4157 has shown impressive efficacy in a phase 2b trial in skin cancer melanoma, leaving the partners speculating about a possible regulatory filing.

Vaccines 120

Vaccines 120

Drug Store News

DECEMBER 15, 2023

Sarah Mastrorocco, vice president and general manager at Instacart Health, discusses the company’s recent collaboration with Mount Sinai Health Systems and the current health ecosystem.

119

119

The Checkup by Singlecare

DECEMBER 15, 2023

You’ve had itchy, watery eyes for days. Or maybe you can’t stop sneezing. Desperate for help, you head to the store for meds that promise allergy relief. Chances are, you walk out with an over-the-counter (OTC) treatment like Zyrtec in hand. Zyrtec is the brand name for cetirizine , an antihistamine used to treat allergy symptoms like itchy eyes, runny nose, and sneezing.

Pharmacy Program Director 116

Pharmacy Program Director Dosage Labelling FDA 116

Pharmacy Times

DECEMBER 15, 2023

Douglas Warner, MD, chief medical officer at eFFECTOR, provides a comprehensive overview of zotatifin and its current status in a Phase 1/2 dose escalation and expansion study, with a focus on ER+/HER2- breast cancer.

108

108

Fierce Healthcare

DECEMBER 15, 2023

Certainly Health, a new patient-facing platform focused on upfront prices, has received $2.3 million in funding. | Certainly claims to be the first marketplace for patients to book doctors with their insurance while avoiding any surprise bills. It's free for patients.

Insurance 110

Insurance 110

Pharmacy Times

DECEMBER 15, 2023

Belzutifan (Welireg; Merck) demonstrated superior progression-free survival compared to everolimus in advanced renal cell carcinoma.

FDA 123

FDA 123

Fierce Healthcare

DECEMBER 15, 2023

Two months ago, Elevance Health and Blue Cross and Blue Shield of Louisiana hit the pause button on a potential $2.5 billion merger in the midst of regulatory scrutiny. | The payers said that they believe coming together will allow BCBSLA to continue "as a vibrant, local company long into the future.

110

110

Pharmacy Times

DECEMBER 15, 2023

Moderate cycling improved cognitive function in patients who got partial or no sleep.

145

145

Fierce Healthcare

DECEMBER 15, 2023

The Centers for Medicare & Medicaid Services is rolling out a new payment model that aims to support state Medicaid agencies in offering whole-person maternal care. | The Centers for Medicare & Medicaid Services is rolling out a new payment model that aims to support state Medicaid agencies in offering whole-person maternal care.

104

104

European Pharmaceutical Review

DECEMBER 15, 2023

Moderna and MSD have announced follow-up data from the Phase IIb clinical trial evaluating cancer vaccine mRNA-4157 (V940) in combination with MSD’s Keytruda in patients with resected high-risk melanoma. The randomised study, KEYNOTE-942, evaluated the treatment in patients with high-risk stage III/IV melanoma. Analysis shows that after three years, treatment with mRNA-4157 (V940) in combination with checkpoint inhibitor Keytruda reduced the risk of recurrence or death by 49 percent compared w

Vaccines 103

Vaccines Research Laboratories Immunization 103

STAT

DECEMBER 15, 2023

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Good morning. What do the numbers say? That’s a question Olivia Goldhill tackled to estimate how many Texans may be struggling to get an abortion for serious medical reasons.

Hospitals 102

Hospitals 102

The Thyroid Pharmacist

DECEMBER 15, 2023

Many moons ago, I was chronically exhausted and needed to sleep for 11 to 12 hours to feel human. Things didn’t get much better, despite starting thyroid medications in 2010, and even going gluten- and dairy-free in 2011. The medication did reduce my cold intolerance, need for sleep by about one hour, and anxiety. Furthermore, eliminating dairy and gluten helped to stop my acid reflux, irritable bowel syndrome, and joint pain, as well as reduced my thyroid antibodies… but my symptoms of fatigue

Immunization 98

Immunization Dosage FDA 98

STAT

DECEMBER 15, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hullo! Turns out Jay Bradner is moving from academia and Novartis to serve as Amgen’s new CSO. Also, the FDA has a new registry of trial sponsors and investigators who didn’t finish their paperwork. Have a nice weekend!

FDA 99

FDA 99

PharmExec

DECEMBER 15, 2023

CDC data show hospitalizations among all age groups spiked by 200% for influenza, 51% for COVID-19, and 60% for respiratory syncytial virus over the past four weeks, emphasizing the need for improved outreach efforts among at-risk populations.

Vaccines 98

Vaccines Hospitals 98

BioPharm

DECEMBER 15, 2023

The US District Court for the District of Massachusetts entered a consent decree of permanent injunction against Pharmasol Corporation for distributing adulterated drugs.

98

98

PharmExec

DECEMBER 15, 2023

In clinical trials, Padcev (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) produced a statistically significant improvement in survival compared to platinum-based chemotherapy alone in patients with locally advanced or metastatic urothelial cancer.

Chemotherapy 98

Chemotherapy FDA 98

European Pharmaceutical Review

DECEMBER 15, 2023

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the conditional approval of Vertex’s gene-editing therapy Casgevy for the treatment of severe sickle cell disease and transfusion-dependent beta thalassemia. Casgevy (exagamglogene autotemcel) is a CRISPR/Cas9 gene-edited cell therapy.

FDA 96

FDA 96

Drug Store News

DECEMBER 15, 2023

The new launches include International Delight’s Bridgerton Berries & Crème, English Toffee creamer and the Berries & Crème Iced Coffee.

105

105

STAT

DECEMBER 15, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

93

93

European Pharmaceutical Review

DECEMBER 15, 2023

Alkermes has agreed to sell its pharmaceutical development and manufacturing facility in Athlone, Ireland to Novo Nordisk for $92.5 million. “The acquisition of the Athlone facility represents an expansion of Novo Nordisk’s global manufacturing setup and will provide Novo Nordisk with additional development and manufacturing capacity for current and future oral products,” commented Thilde G.

89

89